Sotalol — CAS 3930-20-9

Sotalol is a non-selective beta-adrenergic receptor blocking agent with additional Class III antiarrhythmic properties. It is used to treat life-threatening ventricular arrhythmias and atrial fibrillation. Mediocon Inc manufactures GMP-compliant Sotalol API at its Aurangabad facility to international pharmacopoeial standards.

• Life-threatening ventricular arrhythmias
• Atrial fibrillation and flutter
• Cardiac rhythm management
• Beta-adrenergic blockade

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support